Analytical Data
-
基因名
Apolipoprotein A-II/APOA2
- Application
-
别名
rHuApolipoprotein A-II, His; ApoA2; Apolipoprotein A-II
-
种属
Human
-
表达系统
HEK293
-
标签
C-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P02652-1
-
表达区间
A19-Q100
-
蛋白长度
Full Length of Isoform-1 Mature Protein
-
分子量
11 kDa & 13 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Apolipoprotein A-II (APOA2) is a key protein component of high-density lipoprotein (HDL), playing a crucial role in lipid metabolism and cardiovascular health. Research into APOA2 has garnered significant attention, as variations in its gene are associated with altered HDL levels and increased risk of cardiovascular diseases. The recombinant expression of APOA2 provides a valuable tool for studying its biological functions, interactions with lipids, and role in disease mechanisms. Recent studies have focused on the impact of APOA2 on cholesterol efflux and anti-inflammatory properties, which are vital for maintaining cardiovascular health. Additionally, understanding the structure-function relationship of APOA2 through recombinant protein techniques can facilitate the development of novel therapeutic strategies aimed at modulating HDL metabolism and improving cardiovascular outcomes. As researchers continue to unravel the complexities of lipid transport and metabolism, the recombinant expression of APOA2 stands out as a pivotal area of investigation, bridging gaps between fundamental research and clinical implications in heart disease prevention and treatment.
